Geron (GERN) Other financing activities (2019 - 2026)
Geron's (GERN) quarterly Other financing activities came in at $473000.0 in Q2 2026, down 19.97% year-over-year from $591000.0 in Q2 2025, and down 68.7% quarter-over-quarter from $1.5 million in Q1 2026.
Analysis
Geron (GERN) Other financing activities (2019 - 2026) Analysis & Trends
Geron has disclosed Other financing activities across 8 years of filings, most recently posting $473000.0 for Q2 2026.
- In Q2 2026, Other financing activities fell 19.97% year-over-year to $473000.0; the TTM figure through Jun 2026 stood at $3.4 million (down 96.57% YoY), while the FY2025 annual figure was $2.3 million, down 98.19% from the prior year.
- Other financing activities came in at $473000.0 for Q2 2026 at Geron, down from $1.5 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $98.3 million in Q4 2024 to a low of $4000.0 in Q3 2024.
- Average Other financing activities over 5 years is $15.3 million, with a median of $1.5 million recorded in 2026.
- Year-over-year, Other financing activities sank 99.99% in 2024 and surged 13450.0% in 2025.
- Over 5 years, Other financing activities stood at $11.5 million in 2022, then jumped by 145.64% to $28.3 million in 2023, then surged by 247.25% to $98.3 million in 2024, then sank by 99.11% to $878000.0 in 2025, then sank by 46.13% to $473000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $473000.0 in Q2 2026, $1.5 million in Q1 2026, and $878000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 473,000.00 |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 878,000.00 |
| Sep 30, 2025 | 542,000.00 |
| Jun 30, 2025 | 591,000.00 |
| Mar 31, 2025 | 256,000.00 |
| Dec 31, 2024 | 98.30 Mn |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 365,000.00 |
| Mar 31, 2024 | 6.75 Mn |
| Sep 30, 2023 | 28.31 Mn |
| Jun 30, 2023 | 17.77 Mn |
| Mar 31, 2023 | 59.84 Mn |
| Dec 31, 2022 | 11.53 Mn |
| Sep 30, 2022 | 2.88 Mn |
| Jun 30, 2021 | 2.46 Mn |
| Mar 31, 2021 | 17,000.00 |
| Dec 31, 2020 | 111,000.00 |
| Sep 30, 2020 | 16,000.00 |
| Dec 31, 2019 | 37,000.00 |